Samelska Katarzyna, Zaleska-Żmijewska Anna, Bałan Barbara, Grąbczewski Andrzej, Szaflik Jacek Paweł, Kubiak Aleksander Jan, Skopiński Piotr
SPKSO Ophthalmic University Hospital, Warsaw, Poland.
Department of Ophthalmology, Medical University of Warsaw, Warsaw, Poland.
Cent Eur J Immunol. 2021;46(1):111-117. doi: 10.5114/ceji.2021.104328. Epub 2021 Mar 11.
Glaucoma is a degenerative process of the optic nerve. Increased intraocular pressure is believed to be the main factor leading to the glaucomatous damage. The in vitro and animal glaucoma research models provide insight into the molecular changes in the retina in response to the injury factor. The damage is a complex process incorporating molecular and immunological changes. Such changes involve NF B activity and complement activation. The processes affect the human antigen, JNK, MAPK, p53, MT2 and DBA/2J molecular pathways, activate the autophagy processes and compromise neuroprotective mechanisms. Activation and inhibition of immunological responses contribute to cell injury. The immunological mechanisms of glaucomatous degeneration include glial response, the complement, tumor necrosis factor (TNF-) pathways and toll-like receptors athways. Oxidative stress and excitotoxicity are factors contributing to cell death in glaucoma. The authors present an up-to-date review of the mechanisms involved and update on research focusing on a possible innovative glaucoma treatment.
青光眼是一种视神经的退行性病变。眼内压升高被认为是导致青光眼性损害的主要因素。体外和动物青光眼研究模型有助于深入了解视网膜对损伤因素的分子变化。这种损害是一个包含分子和免疫变化的复杂过程。这些变化涉及核因子κB(NFκB)活性和补体激活。这些过程影响人类抗原、应激活化蛋白激酶(JNK)、丝裂原活化蛋白激酶(MAPK)、p53、金属硫蛋白2(MT2)和DBA/2J分子途径,激活自噬过程并损害神经保护机制。免疫反应的激活和抑制都会导致细胞损伤。青光眼性退变的免疫机制包括神经胶质反应、补体、肿瘤坏死因子-α(TNF-α)途径和Toll样受体途径。氧化应激和兴奋性毒性是导致青光眼细胞死亡的因素。作者对所涉及的机制进行了最新综述,并更新了关于青光眼可能创新治疗方法的研究。